Unravelling mutational signatures with plasma circulating tumour DNA
Details
Publication Year 2024-11-14,Volume 15,Issue #1,Page 9876
Journal Title
Nature Communications
Publication Type
Research article
Abstract
The use of circulating tumour DNA (ctDNA) to profile mutational signatures represents a non-invasive opportunity for understanding cancer mutational processes. Here we present MisMatchFinder, a liquid biopsy approach for mutational signature detection using low-coverage whole-genome sequencing of ctDNA. Through analysis of 375 plasma samples across 9 cancers, we demonstrate that MisMatchFinder accurately infers single-base and doublet-base substitutions, as well as insertions and deletions to enhance the detection of ctDNA and clinically relevant mutational signatures.
Publisher
Springer Nature
Keywords
Humans; *Circulating Tumor DNA/genetics/blood; *Mutation; *Neoplasms/genetics/blood; Liquid Biopsy/methods; Whole Genome Sequencing/methods; DNA Mutational Analysis/methods; Biomarkers, Tumor/genetics/blood; DNA, Neoplasm/genetics/blood
Department(s)
Laboratory Research
Open Access at Publisher's Site
https://doi.org/10.1038/s41467-024-54193-2
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-12-12 03:22:38
Last Modified: 2024-12-12 03:29:25

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙